Rigel Pharma (RIGL) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.61 --0%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $5.18 million versus the consensus estimate of $2.67 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
